OxenFree Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STXF
Strive 500 ETF
STXF
|
+$2.22M |
| 2 |
Strive Total Return Bond ETF
STXT
|
+$1.55M |
| 3 |
Strive 1000 Growth ETF
STXG
|
+$933K |
| 4 |
Strive 1000 Dividend Growth ETF
STXD
|
+$727K |
| 5 |
EA Series Trust Strive Small-Cap ETF
STXK
|
+$685K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$7.11K |
| 2 |
Vanguard Mega Cap Growth ETF
MGK
|
+$5.27K |
| 3 |
iShares Russell Top 200 Growth ETF
IWY
|
+$4.9K |
| 4 |
Microsoft
MSFT
|
+$3.04K |
| 5 |
Vanguard Mega Cap Value ETF
MGV
|
+$1.88K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.77% |
| 2 | Healthcare | 0.29% |
| 3 | Financials | 0.27% |
| 4 | Consumer Discretionary | 0.22% |
| 5 | Utilities | 0.22% |
Similar funds
OxenFree Capital's Q2 2025 Portfolio in Review
As of Q2 2025, OxenFree Capital held 45 positions worth $162M, up 24% from $131M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
OxenFree Capital deployed $10.2M of net new capital in Q2 2025, opening 3 new positions and adding to 29 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 371 shares worth $229K.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $7.11K trimmed.
- OxenFree Capital's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 371 shares worth $229K.
- OxenFree Capital added most to Strive 500 ETF in Q2 2025, an estimated $2.22M increase.
- OxenFree Capital's biggest Q2 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $7.11K.
- OxenFree Capital's ten largest holdings make up 74% of its $162M portfolio in Q2 2025.
- OxenFree Capital opened 3 new positions and closed 0 in Q2 2025.
- OxenFree Capital's portfolio value rose 24% quarter-over-quarter to $162M.
Based on OxenFree Capital's 13F filing for Q2 2025, filed 11 Jul 2025.